Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse.

Savdie R, Symons J, Spernat D, Yuen C, Pe Benito RA, Haynes AM, Matthews J, Rasiah KK, Jagavkar RS, Yu C, Fogarty G, Kattan MW, Brenner P, Sutherland RL, Stricker PD.

BJU Int. 2012 Dec;110 Suppl 4:71-6. doi: 10.1111/j.1464-410X.2012.11480.x.

2.

High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.

Savdie R, Horvath LG, Benito RP, Rasiah KK, Haynes AM, Chatfield M, Stricker PD, Turner JJ, Delprado W, Henshall SM, Sutherland RL, Kench JG.

BJU Int. 2012 Jun;109(12):1794-800. doi: 10.1111/j.1464-410X.2011.10572.x. Epub 2011 Oct 12.

3.

The impact of nerve sparing on incidence and location of positive surgical margins in radical prostatectomy.

Moore BM, Savdie R, PeBenito RA, Haynes AM, Matthews J, Delprado W, Rasiah KK, Stricker PD.

BJU Int. 2012 Feb;109(4):533-8. doi: 10.1111/j.1464-410X.2011.10361.x. Epub 2011 Jun 28.

4.

Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer.

Yip PY, Kench JG, Rasiah KK, Benito RP, Lee CS, Stricker PD, Henshall SM, Sutherland RL, Horvath LG.

Prostate. 2011 Nov;71(15):1638-45. doi: 10.1002/pros.21381. Epub 2011 Mar 22.

PMID:
21432866
5.

Should experienced open prostatic surgeons convert to robotic surgery? The real learning curve for one surgeon over 3 years.

Doumerc N, Yuen C, Savdie R, Rahman MB, Rasiah KK, Pe Benito R, Delprado W, Matthews J, Haynes AM, Stricker PD.

BJU Int. 2010 Aug;106(3):378-84. doi: 10.1111/j.1464-410X.2009.09158.x. Epub 2010 Jan 8.

6.

Stage migration in localized prostate cancer has no effect on the post-radical prostatectomy Kattan nomogram.

Thanigasalam R, Rasiah KK, Stricker PD, Haynes AM, Sutherland SI, Sutherland RL, Henshall SM, Horvath LG.

BJU Int. 2010 Mar;105(5):642-7. doi: 10.1111/j.1464-410X.2009.08842.x. Epub 2009 Sep 14.

7.

HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer.

Rasiah KK, Gardiner-Garden M, Padilla EJ, Möller G, Kench JG, Alles MC, Eggleton SA, Stricker PD, Adamski J, Sutherland RL, Henshall SM, Hayes VM.

Mol Cell Endocrinol. 2009 Mar 25;301(1-2):89-96. doi: 10.1016/j.mce.2008.11.021. Epub 2008 Nov 28.

PMID:
19100308
8.

Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.

Rasiah KK, Kench JG, Gardiner-Garden M, Biankin AV, Golovsky D, Brenner PC, Kooner R, O'neill GF, Turner JJ, Delprado W, Lee CS, Brown DA, Breit SN, Grygiel JJ, Horvath LG, Stricker PD, Sutherland RL, Henshall SM.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):711-6.

9.

The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome.

Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ, Johnen H, Russell PJ, Barret W, Stricker PD, Grygiel JJ, Kench JG, Henshall SM, Sutherland RL, Breit SN.

Cancer Res. 2005 Mar 15;65(6):2330-6.

10.

Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma.

Rasiah KK, Stricker PD, Haynes AM, Delprado W, Turner JJ, Golovsky D, Brenner PC, Kooner R, O'Neill GF, Grygiel JJ, Sutherland RL, Henshall SM.

Cancer. 2003 Dec 15;98(12):2560-5.

11.

Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer.

Henshall SM, Afar DE, Rasiah KK, Horvath LG, Gish K, Caras I, Ramakrishnan V, Wong M, Jeffry U, Kench JG, Quinn DI, Turner JJ, Delprado W, Lee CS, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Mack DH, Sutherland RL.

Oncogene. 2003 Sep 4;22(38):6005-12.

PMID:
12955079
12.

Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.

Henshall SM, Afar DE, Hiller J, Horvath LG, Quinn DI, Rasiah KK, Gish K, Willhite D, Kench JG, Gardiner-Garden M, Stricker PD, Scher HI, Grygiel JJ, Agus DB, Mack DH, Sutherland RL.

Cancer Res. 2003 Jul 15;63(14):4196-203.

13.

Laparoscopic repair of a traumatic diaphragmatic hernia.

Rasiah KK, Crowe PJ.

J Laparoendosc Surg. 1995 Dec;5(6):405-7.

PMID:
8746994

Supplemental Content

Loading ...
Support Center